Naudicelle

Naudicelle was a specialized pharmaceutical and nutraceutical company primarily known for its development and marketing of evening primrose oil-based products. The company focused on the therapeutic applications of gamma-linolenic acid (GLA) for conditions such as atopic eczema, premenstrual syndrome, and mastalgia. Historically associated with the pioneering work of David Horrobin and Scotia Pharmaceuticals, Naudicelle's products were among the first to be clinically evaluated for essential fatty acid deficiencies. While the original corporate entity has undergone various transitions and acquisitions, the Naudicelle brand remains a recognized name in the essential fatty acid supplement market.